Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,212 | 581 | 99.3% |
| Education | $60.33 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,060 | 66 | $0 (2024) |
| Amgen Inc. | $974.55 | 71 | $0 (2024) |
| Novo Nordisk Inc | $964.30 | 64 | $0 (2024) |
| PFIZER INC. | $569.51 | 48 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $519.99 | 37 | $0 (2024) |
| Merck Sharp & Dohme LLC | $519.41 | 39 | $0 (2023) |
| GlaxoSmithKline, LLC. | $403.51 | 25 | $0 (2024) |
| Lilly USA, LLC | $352.15 | 25 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $279.49 | 34 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $267.42 | 20 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,028 | 57 | AstraZeneca Pharmaceuticals LP ($311.86) |
| 2023 | $790.59 | 47 | AstraZeneca Pharmaceuticals LP ($138.05) |
| 2022 | $1,232 | 80 | Novo Nordisk Inc ($193.70) |
| 2021 | $1,039 | 69 | Novo Nordisk Inc ($157.88) |
| 2020 | $673.54 | 46 | Amgen Inc. ($171.70) |
| 2019 | $836.21 | 62 | Amgen Inc. ($210.28) |
| 2018 | $1,052 | 84 | Amgen Inc. ($170.91) |
| 2017 | $1,621 | 138 | SANOFI-AVENTIS U.S. LLC ($202.83) |
All Payment Transactions
583 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $52.27 | General |
| Category: Lithoplasty | ||||||
| 09/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Respiratory | ||||||
| 08/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Bone Health | ||||||
| 08/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: PAIN | ||||||
| 07/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Inflammation | ||||||
| 07/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Cardio-renal | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Respiratory | ||||||
| 07/08/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Respiratory | ||||||
| 06/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,343 | 7,072 | $355,172 | $188,505 |
| 2022 | 20 | 2,459 | 6,994 | $375,340 | $191,928 |
| 2021 | 24 | 2,452 | 7,244 | $368,433 | $200,622 |
| 2020 | 25 | 2,480 | 7,237 | $357,029 | $180,690 |
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 405 | 1,209 | $114,900 | $59,282 | 51.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 24 | 2,760 | $62,100 | $47,144 | 75.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 218 | 341 | $46,965 | $24,139 | 51.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 170 | 170 | $23,800 | $18,850 | 79.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 203 | 385 | $36,575 | $8,250 | 22.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 84 | 84 | $8,400 | $6,035 | 71.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 416 | 639 | $8,294 | $5,364 | 64.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 30 | 30 | $6,300 | $4,265 | 67.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 134 | 398 | $15,124 | $3,192 | 21.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 97 | 97 | $3,686 | $2,700 | 73.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 18 | 18 | $4,500 | $2,563 | 57.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 282 | 342 | $3,762 | $1,158 | 30.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $2,200 | $914.33 | 41.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 17 | 17 | $2,040 | $854.76 | 41.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 20 | 23 | $1,472 | $816.50 | 55.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 15 | 25 | $1,325 | $638.94 | 48.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 20 | $2,740 | $618.34 | 22.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 24 | $768.00 | $389.28 | 50.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 13 | 13 | $510.00 | $283.89 | 55.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 11 | 11 | $1,056 | $272.85 | 25.8% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 33 | 53 | $530.00 | $234.77 | 44.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 13 | 13 | $507.00 | $169.73 | 33.5% |
| 90471 | Administration of vaccine | Office | 2023 | 13 | 13 | $494.00 | $148.17 | 30.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 65 | 340 | $6,800 | $113.73 | 1.7% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 28 | 36 | $324.00 | $108.75 | 33.6% |
About Dr. Ronald Bates, DO
Dr. Ronald Bates, DO is a Family Medicine healthcare provider based in Batesville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477540532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Bates, DO has received a total of $8,272 in payments from pharmaceutical and medical device companies, with $1,028 received in 2024. These payments were reported across 583 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($8,212).
As a Medicare-enrolled provider, Bates has provided services to 9,734 Medicare beneficiaries, totaling 28,547 services with total Medicare billing of $761,745. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Batesville, AR
- Active Since 10/04/2005
- Last Updated 09/20/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477540532
Products in Payments
- FARXIGA (Drug) $702.72
- Ozempic (Drug) $574.17
- JARDIANCE (Drug) $474.31
- TRELEGY ELLIPTA (Drug) $327.14
- JANUVIA (Drug) $317.75
- Aimovig (Biological) $287.96
- Edarbi (Drug) $260.79
- Otezla (Drug) $244.84
- EVENITY (Biological) $212.00
- Rybelsus (Drug) $195.23
- Prolia (Biological) $188.66
- INVOKANA (Drug) $153.51
- ELIQUIS (Drug) $153.22
- ENTRESTO (Drug) $137.08
- Trintellix (Drug) $136.54
- XIFAXAN (Drug) $134.92
- PRALUENT (Drug) $132.31
- EMGALITY (Drug) $131.41
- NURTEC ODT (Drug) $128.57
- MOUNJARO (Drug) $122.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Batesville
Dr. Edwin Linder, M.d, M.D
Family Medicine — Payments: $7,165
Dr. John Baker, M.d, M.D
Family Medicine — Payments: $4,289
Dr. David Fielder, Md, MD
Family Medicine — Payments: $3,318
Dr. Michael Havens, M.d, M.D
Family Medicine — Payments: $2,914
Dr. Robert Baker, Md, MD
Family Medicine — Payments: $2,725
Dr. Julia Allen, Md, MD
Family Medicine — Payments: $2,241